Advertisement
Glaukos Corporation

Glaukos Corporation (GKOS) Stock Overview

Explore Glaukos Corporation’s financial performance, market position, analyst ratings, and future outlook.

GKOSNYSE
HealthcareMedical - Devices
$122.94
$0.98(0.80%)
U.S. Market is Open · 11:53
Advertisement

Glaukos Corporation (GKOS)

Meyka AI Score

Z

Key Financials

Market Cap7.4B
P/E Ratio-39.17
EPS (TTM)$-3.31
ROE-0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$142.19
3 Months$66.94
1 Year Target$135.66

GKOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Glaukos Corporation (GKOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $135.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -39.17 and a market capitalization of 7.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.59%
5-Day Change
10.64%
1-Month Change
-5.38%
3-Month Change
19.44%
6-Month Change
18.22%
Year-to-Date (YTD) Change
11.89%
1-Year Change
33.50%
3-Year Change
87.59%
5-Year Change
60.86%
All-Time (Max) Change
304.68%

Contact Information

949 367 9600
229 Avenida Fabricante, Aliso Viejo, CA, 92672

Company Facts

995 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions